共 46 条
Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
被引:22
作者:
Bail, Kathrin
[1
]
Notz, Quirin
[1
]
Rovituso, Damiano M.
[1
]
Schampel, Andrea
[1
]
Wunsch, Marie
[1
]
Koeniger, Tobias
[1
]
Schropp, Verena
[6
]
Bharti, Richa
[2
]
Scholz, Claus-Juergen
[2
,3
]
Foerstner, Konrad U.
[2
]
Kleinschnitz, Christoph
[4
,5
]
Kuerten, Stefanie
[1
,6
]
机构:
[1] Univ Wurzburg, Dept Anat & Cell Biol, Wurzburg, Germany
[2] Univ Hosp Wurzburg, Core Unit Syst Med, Wurzburg, Germany
[3] Univ Bonn, LIMES Inst, Bonn, Germany
[4] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany
[5] Univ Hosp Essen, Dept Neurol, Essen, Germany
[6] Friedrich Alexander Univ Erlangen Nurnberg, Inst Anat & Cell Biol, Erlangen, Germany
来源:
JOURNAL OF NEUROINFLAMMATION
|
2017年
/
14卷
关键词:
B cells;
EAE;
Fingolimod;
FTY720;
Multiple sclerosis;
TLO;
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;
CENTRAL-NERVOUS-SYSTEM;
CORTICAL PATHOLOGY;
LYMPHOCYTE EGRESS;
FINGOLIMOD FTY720;
INFLAMMATION;
INDUCTION;
FOLLICLES;
IMMUNE;
IMMUNOSUPPRESSION;
D O I:
10.1186/s12974-017-0924-4
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Background: MP4-induced experimental autoimmune encephalomyelitis (EAE) is a mouse model of multiple sclerosis (MS), which enables targeted research on B cells, currently much discussed protagonists in MS pathogenesis. Here, we used this model to study the impact of the S1P1 receptor modulator FTY720 (fingolimod) on the autoreactive B cell and antibody response both in the periphery and the central nervous system (CNS). Methods: MP4-immunized mice were treated orally with FTY720 for 30 days at the peak of disease or 50 days after EAE onset. The subsequent disease course was monitored and the MP4-specific B cell/antibody response was measured by ELISPOT and ELISA. RNA sequencing was performed to determine any effects on B cell-relevant gene expression. S1P1 receptor expression by peripheral T and B cells, B cell subset distribution in the spleen and B cell infiltration into the CNS were studied by flow cytometry. The formation of B cell aggregates and of tertiary lymphoid organs (TLOs) was evaluated by histology and immunohistochemistry. Potential direct effects of FTY720 on B cell aggregation were studied in vitro. Results: FTY720 significantly attenuated clinical EAE when treatment was initiated at the peak of EAE. While there was a significant reduction in the number of T cells in the blood after FTY720 treatment, B cells were only slightly diminished. Yet, there was evidence for the modulation of B cell receptor-mediated signaling upon FTY720 treatment. In addition, we detected a significant increase in the percentage of B220(+) B cells in the spleen both in acute and chronic EAE. Whereas acute treatment completely abrogated B cell aggregate formation in the CNS, the numbers of infiltrating B cells and plasma cells were comparable between vehicle-and FTY720-treated mice. In addition, there was no effect on already developed aggregates in chronic EAE. In vitro B cell aggregation assays suggested the absence of a direct effect of FTY720 on B cell aggregation. However, FTY720 impacted the evolution of B cell aggregates into TLOs. Conclusions: The data suggest differential effects of FTY720 on the B cell compartment in MP4-induced EAE.
引用
收藏
页数:15
相关论文